Acumen Pharmaceuticals

(NASDAQ) ABOS

Current Price$2.47

Market Cap$185.62M

Since IPO (2021)-87%

5 YearN/A

1 Year+157%

1 Month-7%

Acumen Pharmaceuticals Financials at a Glance

Market Cap

$185.62M

Revenue (TTM)

$0.00

Net Income (TTM)

$121.33M

EPS (TTM)

$-2.00

P/E Ratio

-1.28

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.47

Volume

328,304.923

Open

$2.54

Price

$2.47

Volume

328,304.923

Open

$2.54

Previous Close

$2.47

Daily Range

$2.40 - $2.59

52-Week Range

$0.96 - $3.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.47

Volume

328,304.923

Open

$2.54

Previous Close

$2.47

Daily Range

$2.40 - $2.59

52-Week Range

$0.96 - $3.60

ABOS News

Why Shares of Acumen Pharmaceuticals Are Down Tuesday

James HalleyJul 18, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acumen Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Daniel J. O'Connell, MBA

Website

www.acumenpharm.com

Headquarters

Newton, VA 22902, US

ABOS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-96%

Return on Capital

-1%

Return on Assets

-99%

Earnings Yield

-78.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$185.62M

Shares Outstanding

72.23M

Volume

328.30K

Avg. Volume

542.31K

Financials (TTM)

Gross Profit

$184.00K

Operating Income

$123.83M

EBITDA

$123.83M

Operating Cash Flow

$115.54M

Capital Expenditure

$88.00K

Free Cash Flow

$115.63M

Cash & ST Invst.

$116.86M

Total Debt

$31.31M

Acumen Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$45.00K

-2.3%

Gross Margin

0.00%

N/A

Market Cap

$185.62M

N/A

Market Cap/Employee

$3.04M

N/A

Employees

N/A

Net Income

$25.14M

+32.3%

EBITDA

$25.11M

+30.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$85.55M

-39.7%

Accounts Receivable

$625.00K

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$22.40M

-24.3%

Short Term Debt

$8.91M

+6603.0%

Return on Assets

-98.78%

N/A

Return on Invested Capital

-1.33%

N/A

Free Cash Flow

$19.10M

+29.8%

Operating Cash Flow

$19.10M

+29.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.51-0.79%

AGENAgenus Inc.

AGENAgenus Inc.$3.75-3.60%

SEERSeer, Inc.

SEERSeer, Inc.$1.88-0.53%

ALECAlector, Inc.

ALECAlector, Inc.$2.44-5.06%

FATEFate Therapeutics, Inc.

FATEFate Therapeutics, Inc.$2.43+6.11%

ACTUActuate Therapeutics Inc

ACTUActuate Therapeutics Inc$3.34+11.71%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.72-3.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.35-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

TSLATesla

TSLATesla$411.79+0.03%

Questions About ABOS

What is the current price of Acumen Pharmaceuticals?

Acumen Pharmaceuticals is trading at $2.47 per share.

What is the 52-week range for Acumen Pharmaceuticals?

Over the past 52 weeks, Acumen Pharmaceuticals has traded between $0.96 and $3.60.

How much debt does Acumen Pharmaceuticals have?

As of the most recent reporting period, Acumen Pharmaceuticals reported total debt of $31.31M.

How much cash does Acumen Pharmaceuticals have on hand?

Acumen Pharmaceuticals reported $53.99M in cash and cash equivalents in its most recent financial results.

What is Acumen Pharmaceuticals’s dividend yield?

Acumen Pharmaceuticals does not currently have a dividend yield.

Acumen Pharmaceuticals

Acumen Pharmaceuticals Financials at a Glance

ABOS News

Why Shares of Acumen Pharmaceuticals Are Down Tuesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acumen Pharmaceuticals

ABOS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acumen Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ABOS

What is the current price of Acumen Pharmaceuticals?

What is the 52-week range for Acumen Pharmaceuticals?

How much debt does Acumen Pharmaceuticals have?

How much cash does Acumen Pharmaceuticals have on hand?

What is Acumen Pharmaceuticals’s dividend yield?

Premium Investing Services